Rezolute (RZLT) Amortizatization of Intangibles (2012 - 2026)
Rezolute (RZLT) reported Amortizatization of Intangibles of $481000.0 for Q1 2026, down 4.18% on a YoY basis from $502000.0 in Q1 2025, and down 32.54% sequentially from $713000.0 in Q4 2025.
Rezolute (RZLT) Amortizatization of Intangibles (2012 - 2026) Analysis & Trends
Rezolute (RZLT) has 9 years of Amortizatization of Intangibles data on file, last reported at $481000.0 in Q1 2026.
- For the quarter ending Q1 2026, Amortizatization of Intangibles fell 4.18% year-over-year to $481000.0; the trailing twelve-month figure through Mar 2026 stood at $2.3 million (down 16.74% YoY), and the FY2025 full-year result was $2.4 million, down 15.62% from the prior year.
- Amortizatization of Intangibles slipped to $481000.0 in Q1 2026, from $713000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $2.2 million in Q4 2023 to a low of -$973000.0 in Q3 2023.
- A 4-year average of $657166.7 and a median of $718000.0 in 2024 frame the typical range for Amortizatization of Intangibles.
- Peak annual rise in Amortizatization of Intangibles reached 185.71% in 2024, while the deepest fall reached 66.43% in 2024.
- Tracing RZLT's Amortizatization of Intangibles over 4 years: stood at $2.2 million in 2023, then plunged by 66.43% to $723000.0 in 2024, then declined by 1.38% to $713000.0 in 2025, then slumped by 32.54% to $481000.0 in 2026.
- Business Quant data shows RZLT's Amortizatization of Intangibles at $481000.0 in Q1 2026, $713000.0 in Q4 2025, and $799000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | Rezolute | 517.94 Mn | 517.94 Mn | - | 481,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 481,000.00 |
| Mar 31, 2026 | 481,000.00 |
| Dec 31, 2025 | 713,000.00 |
| Dec 31, 2025 | 713,000.00 |
| Sep 30, 2025 | 799,000.00 |
| Sep 30, 2025 | 799,000.00 |
| Jun 30, 2025 | 335,000.00 |
| Jun 30, 2025 | 335,000.00 |
| Mar 31, 2025 | 502,000.00 |
| Mar 31, 2025 | 502,000.00 |
| Dec 31, 2024 | 723,000.00 |
| Dec 31, 2024 | 723,000.00 |
| Sep 30, 2024 | 834,000.00 |
| Sep 30, 2024 | 834,000.00 |
| Jun 30, 2024 | 737,000.00 |
| Jun 30, 2024 | 737,000.00 |
| Mar 31, 2024 | 919,000.00 |
| Mar 31, 2024 | 919,000.00 |
| Dec 31, 2023 | 2.15 Mn |
| Dec 31, 2023 | 2.15 Mn |